DOK6 and acute myeloid leukemia: Firstly, DOK6 methylation status was examined by MSP, and the results showed that the DOK6 promoter methylation level of AML patients is significantly higher than controls, with a median of 0.231 vs 0.060 (P = .037; Figure 1B).